Other Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26 Drug ChannelsToday's guest post comes from Chrissy Hand, Chief Product and Commercial Officer at CoverMyMeds.OtherRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Drug Channels Today’s guest post comes from Chrissy Hand, Chief Product and Commercial Officer at CoverMyMeds. OtherRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Merck KGaA acquires JSR chromatography businessNext: Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
